ArticleFederal practitioner : for the health care professionals of the VA, DoD, and PHS2026
A Case of Birt-Hogg-Dubé Syndrome: A Rare but Essential Diagnosis to Consider.
Article in Federal practitioner : for the health care professionals of the VA, DoD, and PHS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Birt-Hogg-Dubé syndrome (BHD) is an autosomal dominant disorder characterized by multiple pulmonary cysts, predisposing individuals to spontaneous pneumothorax, cutaneous lesions-specifically fibrofolliculomas-and an increased risk of renal malignancies. Although diagnosing BHD is difficult due to the variable presentation of the disease, identification is crucial for proper management, which includes lifelong screening for renal malignancies and management of recurrent pneumothoraces. Despite its rarity, maintaining awareness of BHD in the differential diagnosis of pulmonary cysts is essential. Case Presentation: We present the case of a nonsmoking male veteran in his 60s whose BHD diagnosis surfaced many years after a history of recurrent pneumothoraces, leading to 1 pleurodesis in each lung. Genetic testing of the Conclusions: BHD is a rare and complex disease. Early recognition and diagnosis play a pivotal role in preventing potentially severe complications such as renal malignancies. Suspicion for a genetic disorder such as BHD, lymphangioleiomyomatosis, or pulmonary Langerhans cell histiocytosis should arise in patients who experience spontaneous pneumothorax, especially in the presence of multiple cystic lesions or a family history of pneumothoraces. Early consideration of pleurodesis after the first spontaneous pneumothorax is recommended. The complex presentation of BHD may delay recognition, which can be exacerbated by variable continuity of care.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.